Connection

Roland Schmid to Pyrimidines

Back to Details
This is a "connection" page, showing publications Roland Schmid has written about Pyrimidines.
Roland Schmid
Connection Strength
0.042
Pyrimidines
  1. MTOR inhibitor-based combination therapies for pancreatic cancer. Br J Cancer. 2018 02 06; 118(3):366-377.
    View in: PubMed
    Score: 0.025
  2. Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma. BMC Cancer. 2012 Dec 10; 12:587.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.